Douglas Hutchens
Director/Board Member at ANIMALCARE GROUP PLC
Profile
Douglas Eugene Hutchens is an Independent Non-Executive Director at Animalcare Group Plc and the Chief Scientific Officer at Animol Discovery.
He was previously a Director at Crenae Therapeutics, Inc. and the Chief Veterinary Officer & Executive VP at Bayer Animal Health.
He also worked as an Assistant Professor at the University of Illinois College of Veterinary Medicine.
Hutchens holds a doctorate degree from the University of Illinois.
Douglas Hutchens active positions
| Companies | Position | Start |
|---|---|---|
| ANIMALCARE GROUP PLC | Director/Board Member | 2022-02-09 |
Animol Discovery
 Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | - |
Former positions of Douglas Hutchens
| Companies | Position | End |
|---|---|---|
| Crenae Therapeutics, Inc. | Director/Board Member | 2022-07-31 |
Bayer Animal Health
 Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Corporate Officer/Principal | 2020-06-30 |
| University of Illinois College of Veterinary Medicine | Corporate Officer/Principal | - |
Training of Douglas Hutchens
| University of Illinois | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANIMALCARE GROUP PLC | Health Technology |
| Private companies | 3 |
|---|---|
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Health Technology |
Animol Discovery
Animol Discovery Pharmaceuticals: MajorHealth Technology Animol Discovery develops small molecule drugs for animals. The company was founded by Phil Austin in 2019 and is headquartered in Boston, MA. | Health Technology |
| Crenae Therapeutics, Inc. |
- Stock Market
- Insiders
- Douglas Hutchens
